| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.5 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.5 |